Acquiring Company
CONMED Corporation
Acquired Company
In2Bones Global
Description
CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately-held In2Bones Global, Inc. (In2Bones), on a cash-free, debt-free basis, for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period. The transaction is not subject to a financing condition. The transaction is subject to customary closing conditions, including receipt of U.S. regulatory approval, and is expected to close late in the second quarter or early in the third quarter of 2022.
Fundz sees it the moment CONMED Corporation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired In2Bones Global?
In2Bones Global was acquired by CONMED Corporation, based in Tampa Bay. The deal was reported on May 4, 2022. CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. CONMED Corporation is publicly traded (CNMD) and operates in Manufacturing.
When did CONMED Corporation acquire In2Bones Global?
CONMED Corporation's acquisition of In2Bones Global was reported on May 4, 2022. CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately-held In2Bones Global, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does In2Bones Global do?
Headquartered in Memphis, Tennessee, In2Bones is a global developer manufacturer and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. It is privately held, operating in Manufacturing.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.